Renaissance Technologies’s Cellectar Biosciences CLRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,283
| Closed | -$392K | – | 3544 |
|
|
2024
Q1 | $392K | Buy |
+3,283
| New | +$392K | ﹤0.01% | 2969 |
|
|
2023
Q4 | – | Sell |
-723
| Closed | -$57K | – | 3782 |
|
|
2023
Q3 | $57K | Sell |
723
-1,410
| -66% | -$111K | ﹤0.01% | 3376 |
|
|
2023
Q2 | $125K | Buy |
2,133
+220
| +12% | +$12.9K | ﹤0.01% | 3421 |
|
|
2023
Q1 | $82K | Buy |
1,913
+355
| +23% | +$15.2K | ﹤0.01% | 3548 |
|
|
2022
Q4 | $80K | Buy |
1,558
+968
| +164% | +$49.7K | ﹤0.01% | 3689 |
|
|
2022
Q3 | $59K | Buy |
590
+35
| +6% | +$3.5K | ﹤0.01% | 3711 |
|
|
2022
Q2 | $67K | Buy |
555
+132
| +31% | +$15.9K | ﹤0.01% | 3942 |
|
|
2022
Q1 | $87K | Buy |
423
+23
| +6% | +$4.73K | ﹤0.01% | 3819 |
|
|
2021
Q4 | $80K | Sell |
400
-1,090
| -73% | -$218K | ﹤0.01% | 3717 |
|
|
2021
Q3 | $414K | Sell |
1,490
-1,881
| -56% | -$523K | ﹤0.01% | 2955 |
|
|
2021
Q2 | $1.2M | Buy |
3,371
+396
| +13% | +$141K | ﹤0.01% | 2571 |
|
|
2021
Q1 | $1.44M | Buy |
2,975
+2,072
| +229% | +$1M | ﹤0.01% | 2420 |
|
|
2020
Q4 | $563K | Sell |
903
-568
| -39% | -$354K | ﹤0.01% | 2766 |
|
|
2020
Q3 | $547K | Sell |
1,471
-1,164
| -44% | -$433K | ﹤0.01% | 2784 |
|
|
2020
Q2 | $1.01M | Buy |
2,635
+1,861
| +240% | +$715K | ﹤0.01% | 2530 |
|
|
2020
Q1 | $309K | Buy |
774
+111
| +17% | +$44.3K | ﹤0.01% | 2967 |
|
|
2019
Q4 | $448K | Buy |
663
+73
| +12% | +$49.3K | ﹤0.01% | 2945 |
|
|
2019
Q3 | $354K | Buy |
590
+180
| +44% | +$108K | ﹤0.01% | 2985 |
|
|
2019
Q2 | $268K | Buy |
410
+221
| +117% | +$144K | ﹤0.01% | 3214 |
|
|
2019
Q1 | $133K | Sell |
189
-1
| -0.5% | -$704 | ﹤0.01% | 3267 |
|
|
2018
Q4 | $88K | Sell |
190
-5
| -3% | -$2.32K | ﹤0.01% | 3248 |
|
|
2018
Q3 | $176K | Buy |
+195
| New | +$176K | ﹤0.01% | 3171 |
|